Affinity Asset Advisors, LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Affinity Asset Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $2.37 Million - $2.84 Million	-150,000 Reduced 13.04%	1,000,000 $18 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $6.45 Million - $8.79 Million	-505,000 Reduced 30.51%	1,150,000 $18.7 Million
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $2.72 Million - $3.68 Million	255,000 Added 18.21%	1,655,000 $23.4 Million
Q4 2023 Feb 13, 2024	BUY	$8.12 - $10.63 $2.44 Million - $3.19 Million	300,000 Added 27.27%	1,400,000 $14.6 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $8.23 Million - $11.8 Million	1,100,000 New	1,100,000 $11.2 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.7B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.